Last price paid | 0.13 | |
Change | +85.71% [ +0.06 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 31.05.2024 17:20 |
Fixing | 21.06.2024 |
Settlement date | 11.10.2023 |
Last trading | 21.06.2024 |
Final fixing | 21.06.2024 |
Currency redemption | CHF |
Perf. since issue | -38.64% |
Year to date (YTD) | +100.00% |
1 month | +62.50% |
3 months | +30.00% |
1 year | n.a. |
3 years | n.a. |
Issue price | 0.22 |
Underlying price on issue | 87.81 |
Premium | 0.01% |
Premium p.a. | 0.13% |
Leverage | 31.15 |
Implied volatility | 0.13 |
ISIN | CH1281033113 |
Symbol | NOV7HZ |
Security | 128103311 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | 28.06.2024 |
Underlying | Novartis N, CH0012005267 |
Underlying ISIN | CH0012005267 |
Strike | 92.00 |
C/P type | call |
Subscription ratio | 15.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | American |
Delivery of securities | On Demand |
Minimum execution | 15 |
Value day | 04.10.2023 |
Premium | 1.00% |
Premium p.a. | 13.04% |
Leverage | 49.19 |
Implied volatility | 12.63% |
Moneyness | in-the-money |
Leverage | 31.1512 |
Delta | 0.6333 |
Gamma | 0.0082 |
Theta | -0.0017 |
Rho | 0.0031 |
Vega | 0.0069 |
Fair value | 0.07 |
Intrinsic value | n.a. |
Break-even | 93.89 |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Warrant (2100) |
Name | Price |
---|---|
Swiss Re | 114.70 |
NOVARTIS N | 93.17 |
KUEHNE & NAGEL | 255.50 |
SWISSCOM N | 498.20 |
Nestlé SA | 95.56 |
Name | Price |
---|---|
Sika AG | 272.90 |
GEBERIT N | 550.40 |
Holcim | 78.78 |
Lonza Group | 486.40 |
Partners Group Ho... | 1'206.00 |